Background: Seizure control doesn't represent the only challenging goal in patients with brain tumor-related epilepsy. Side effects have often taken precedence for patients' quality of life.

Methods: We performed an observational retrospective study on patients with brain tumor-related epilepsy: 35 who had assumed oxcarbazepine monotherapy and 35 patients who had undergone treatment with traditional antiepileptic drugs. Primary variable of efficacy was the mean seizure frequency per month and safety variables were the drop-out for side effects and total incidence of side effects. We applied the Propensity Score technique to minimize selection bias.

Results: Our results showed a similar efficacy of oxcarbazepine and traditional antiepileptic drugs over time, but the difference in safety and tolerability between the two groups was significant: traditional AEDs caused more side effects, both serious and non serious.

Conclusion: This study highlights the importance of taking into consideration not only seizure control but also the appearance of side effects when choosing antiepileptic drugs in this patients population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686682PMC
http://dx.doi.org/10.1186/1756-9966-28-60DOI Listing

Publication Analysis

Top Keywords

side effects
24
antiepileptic drugs
16
brain tumor-related
12
tumor-related epilepsy
12
traditional antiepileptic
12
seizure control
8
patients brain
8
effects
6
antiepileptic
5
side
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!